4.7 Article

Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses

Journal

BLOOD
Volume 113, Issue 16, Pages 3716-3725

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-09-179754

Keywords

-

Categories

Funding

  1. Ministere de l'Enseignement Superieur et de la Recherche
  2. Institut Pasteur and Inserm
  3. Agence Nationale de la Recherche (Paris, France) [05-JCJC-023601]
  4. Fondation pour la Recherche Medicale (Paris, France)
  5. Defis de la Recherche en Allergologie
  6. PTR/PIC Institut Pasteur-Institut Curie (Paris, France)
  7. European Union [LSHG CT 2005-005203]
  8. Laboratoire Francais du fractionnement et des Biotechnologies (LFB)

Ask authors/readers for more resources

Distinct genes encode 6 human receptors for IgG (hFc gamma Rs), 3 of which have 2 or 3 polymorphic variants. The specificity and affinity of individual hFc gamma Rs for the 4 human IgG subclasses is unknown. This information is critical for antibody-based immunotherapy which has been increasingly used in the clinics. We investigated the binding of polyclonal and monoclonal IgG1, IgG2, IgG3, and IgG4 to Fc gamma RI; Fc gamma RIIA, IIB, and IIC; Fc gamma RIIIA and IIIB; and all known polymorphic variants. Wild-type and low-fucosylated IgG1 anti-CD20 and anti-RhD mAbs were also examined. We found that (1) IgG1 and IgG3 bind to all hFc gamma Rs; (2) IgG2 bind not only to Fc gamma RIIA(H131), but also, with a lower affinity, to Fc gamma RIIA(R131) and Fc gamma RIIIA(V158); (3) IgG4 bind to Fc gamma RI, Fc gamma RIIA, IIB and IIC and Fc gamma RIIIA(V158); and (4) the inhibitory receptor Fc gamma RIIB has a lower affinity for IgG1, IgG2, and IgG3 than all other hFc gamma Rs. We also identified parameters that determine the specificity and affinity of hFc gamma Rs for IgG subclasses. These results document how hFc gamma R specificity and affinity may account for the biological activities of antibodies. They therefore highlight the role of specific hFc gamma Rs in the therapeutic and pathogenic effects of antibodies in disease. (Blood. 2009; 113: 3716-3725)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available